Study Links Popular Diabetes and Weight-Loss Drug to Irreversible Blindness

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following a recent study that suggests a link between the medications and a sudden, irreversible form of vision loss. The condition, known as Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), has reportedly affected thousands of users, with legal claims now totaling billions of dollars.

The core of the legal action revolves around the alleged failure of Novo Nordisk to adequately warn consumers about the potential for vision-related side effects.

“The American Association of Ophthalmology suggests that Ozempic and other GLP-1 drugs can cause blindness or vision loss in several ways,” Robert

See Full Page